Ohya, Yusuke
Sakima, Atsushi
Arima, Hisatomi
Fukami, Ako
Furuhashi, Masato
Ishida, Mari
Ishimitsu, Toshihiko
Kai, Hisashi
Matsumura, Kiyoshi
Miura, Katsuyuki
Mukoyama, Masashi
Munakata, Masanori
Ohkubo, Takatoshi
Rakugi, Hiromi
Takami, Takeshi
Tsuchihashi, Takuya
Hirawa, Nobuhito
Article History
Received: 1 August 2025
Accepted: 1 August 2025
First Online: 29 August 2025
Compliance with ethical standards
:
: The Task Force Committee for the JSH2025 was established in accordance with the Guidance on Eligibility Criteria for Participation in Clinical Practice Guideline Development 2023 issued by the Japan Medical Association. The committee members were selected based on the Conflict of Interest (COI) Management Policy for JSH2025. Declarations of COI for all committee members over the past 3 fiscal years (2022–2024) have been disclosed and are publicly available on the website of the Japanese Society of Hypertension.
Free to read: This content has been made available to all.